3.26.1 html 259 462 1 false 99 0 false 13 false false R1.htm 0000001 - Document - Cover Sheet http://www.eyegatepharma.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Document - Audit Information Sheet http://www.eyegatepharma.com/role/AuditInformation Audit Information Cover 2 false false R3.htm 9952151 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.eyegatepharma.com/role/CONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Statements 3 false false R4.htm 9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.eyegatepharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 4 false false R5.htm 9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) Sheet http://www.eyegatepharma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) Statements 5 false false R6.htm 9952154 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://www.eyegatepharma.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 9952155 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) Sheet http://www.eyegatepharma.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) Statements 7 false false R8.htm 9952156 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.eyegatepharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 9952157 - Disclosure - Business, Presentation and Recent Accounting Pronouncements Sheet http://www.eyegatepharma.com/role/BusinessPresentationandRecentAccountingPronouncements Business, Presentation and Recent Accounting Pronouncements Notes 9 false false R10.htm 9952158 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.eyegatepharma.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 9952159 - Disclosure - Fair Value Sheet http://www.eyegatepharma.com/role/FairValue Fair Value Notes 11 false false R12.htm 9952160 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://www.eyegatepharma.com/role/PrepaidExpensesandOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 12 false false R13.htm 9952161 - Disclosure - Property and Equipment Sheet http://www.eyegatepharma.com/role/PropertyandEquipment Property and Equipment Notes 13 false false R14.htm 9952162 - Disclosure - Accrued Expenses Sheet http://www.eyegatepharma.com/role/AccruedExpenses Accrued Expenses Notes 14 false false R15.htm 9952163 - Disclosure - Intangible Assets and In-Process R&D Sheet http://www.eyegatepharma.com/role/IntangibleAssetsandInProcessRD Intangible Assets and In-Process R&D Notes 15 false false R16.htm 9952164 - Disclosure - Capital Stock Sheet http://www.eyegatepharma.com/role/CapitalStock Capital Stock Notes 16 false false R17.htm 9952165 - Disclosure - Warrants Sheet http://www.eyegatepharma.com/role/Warrants Warrants Notes 17 false false R18.htm 9952166 - Disclosure - Equity Incentive Plan Sheet http://www.eyegatepharma.com/role/EquityIncentivePlan Equity Incentive Plan Notes 18 false false R19.htm 9952167 - Disclosure - Income Taxes Sheet http://www.eyegatepharma.com/role/IncomeTaxes Income Taxes Notes 19 false false R20.htm 9952168 - Disclosure - Commitments and Contingencies Sheet http://www.eyegatepharma.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 20 false false R21.htm 9952169 - Disclosure - Employee Benefit Plans Sheet http://www.eyegatepharma.com/role/EmployeeBenefitPlans Employee Benefit Plans Notes 21 false false R22.htm 9952170 - Disclosure - Segment Information Sheet http://www.eyegatepharma.com/role/SegmentInformation Segment Information Notes 22 false false R23.htm 9952171 - Disclosure - Roll-forward of TOI Activity Sheet http://www.eyegatepharma.com/role/RollforwardofTOIActivity Roll-forward of TOI Activity Notes 23 false false R24.htm 9952172 - Disclosure - Prepaid Collaboration Expenses and Accrued Collaboration Credit Sheet http://www.eyegatepharma.com/role/PrepaidCollaborationExpensesandAccruedCollaborationCredit Prepaid Collaboration Expenses and Accrued Collaboration Credit Notes 24 false false R25.htm 9952173 - Disclosure - Subsequent Events Sheet http://www.eyegatepharma.com/role/SubsequentEvents Subsequent Events Notes 25 false false R26.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 26 false false R27.htm 995447 - Disclosure - Insider Trading Policies and Procedures Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc Insider Trading Policies and Procedures Notes 27 false false R28.htm 995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure Sheet http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure Cybersecurity Risk Management and Strategy Disclosure Notes 28 false false R29.htm 9955511 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.eyegatepharma.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.eyegatepharma.com/role/BusinessPresentationandRecentAccountingPronouncements 29 false false R30.htm 9955512 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.eyegatepharma.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.eyegatepharma.com/role/SummaryofSignificantAccountingPolicies 30 false false R31.htm 9955513 - Disclosure - Fair Value (Tables) Sheet http://www.eyegatepharma.com/role/FairValueTables Fair Value (Tables) Tables http://www.eyegatepharma.com/role/FairValue 31 false false R32.htm 9955514 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.eyegatepharma.com/role/PrepaidExpensesandOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://www.eyegatepharma.com/role/PrepaidExpensesandOtherCurrentAssets 32 false false R33.htm 9955515 - Disclosure - Property and Equipment (Tables) Sheet http://www.eyegatepharma.com/role/PropertyandEquipmentTables Property and Equipment (Tables) Tables http://www.eyegatepharma.com/role/PropertyandEquipment 33 false false R34.htm 9955516 - Disclosure - Accrued Expenses (Tables) Sheet http://www.eyegatepharma.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://www.eyegatepharma.com/role/AccruedExpenses 34 false false R35.htm 9955517 - Disclosure - Intangible Assets and In-Process R&D (Tables) Sheet http://www.eyegatepharma.com/role/IntangibleAssetsandInProcessRDTables Intangible Assets and In-Process R&D (Tables) Tables http://www.eyegatepharma.com/role/IntangibleAssetsandInProcessRD 35 false false R36.htm 9955518 - Disclosure - Warrants (Tables) Sheet http://www.eyegatepharma.com/role/WarrantsTables Warrants (Tables) Tables http://www.eyegatepharma.com/role/Warrants 36 false false R37.htm 9955519 - Disclosure - Equity Incentive Plan (Tables) Sheet http://www.eyegatepharma.com/role/EquityIncentivePlanTables Equity Incentive Plan (Tables) Tables http://www.eyegatepharma.com/role/EquityIncentivePlan 37 false false R38.htm 9955520 - Disclosure - Income Taxes (Tables) Sheet http://www.eyegatepharma.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.eyegatepharma.com/role/IncomeTaxes 38 false false R39.htm 9955521 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.eyegatepharma.com/role/CommitmentsandContingenciesTables Commitments and Contingencies (Tables) Tables http://www.eyegatepharma.com/role/CommitmentsandContingencies 39 false false R40.htm 9955522 - Disclosure - Segment Information (Tables) Sheet http://www.eyegatepharma.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.eyegatepharma.com/role/SegmentInformation 40 false false R41.htm 9955523 - Disclosure - Roll-forward of TOI Activity (Tables) Sheet http://www.eyegatepharma.com/role/RollforwardofTOIActivityTables Roll-forward of TOI Activity (Tables) Tables http://www.eyegatepharma.com/role/RollforwardofTOIActivity 41 false false R42.htm 9955524 - Disclosure - Prepaid Collaboration Expenses and Accrued Collaboration Credit (Tables) Sheet http://www.eyegatepharma.com/role/PrepaidCollaborationExpensesandAccruedCollaborationCreditTables Prepaid Collaboration Expenses and Accrued Collaboration Credit (Tables) Tables http://www.eyegatepharma.com/role/PrepaidCollaborationExpensesandAccruedCollaborationCredit 42 false false R43.htm 9955525 - Disclosure - Business, Presentation and Recent Accounting Pronouncements (Details) Sheet http://www.eyegatepharma.com/role/BusinessPresentationandRecentAccountingPronouncementsDetails Business, Presentation and Recent Accounting Pronouncements (Details) Details 43 false false R44.htm 9955526 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) Sheet http://www.eyegatepharma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails Summary of Significant Accounting Policies - Narrative (Details) Details 44 false false R45.htm 9955527 - Disclosure - Summary of Significant Accounting Policies - Net Income (Loss) per Share ??? Basic and Diluted (Details) Sheet http://www.eyegatepharma.com/role/SummaryofSignificantAccountingPoliciesNetIncomeLossperShareBasicandDilutedDetails Summary of Significant Accounting Policies - Net Income (Loss) per Share ??? Basic and Diluted (Details) Details 45 false false R46.htm 9955528 - Disclosure - Summary of Significant Accounting Policies - Assets at Fair Value (Details) Sheet http://www.eyegatepharma.com/role/SummaryofSignificantAccountingPoliciesAssetsatFairValueDetails Summary of Significant Accounting Policies - Assets at Fair Value (Details) Details 46 false false R47.htm 9955529 - Disclosure - Summary of Significant Accounting Policies - Liabilities at Fair Value (Details) Sheet http://www.eyegatepharma.com/role/SummaryofSignificantAccountingPoliciesLiabilitiesatFairValueDetails Summary of Significant Accounting Policies - Liabilities at Fair Value (Details) Details 47 false false R48.htm 9955530 - Disclosure - Fair Value - Short-term Investments (Details) Sheet http://www.eyegatepharma.com/role/FairValueShorttermInvestmentsDetails Fair Value - Short-term Investments (Details) Details 48 false false R49.htm 9955531 - Disclosure - Fair Value - Maturities of Short-term Investments (Details) Sheet http://www.eyegatepharma.com/role/FairValueMaturitiesofShorttermInvestmentsDetails Fair Value - Maturities of Short-term Investments (Details) Details 49 false false R50.htm 9955532 - Disclosure - Fair Value - Available-for-Sale Investments Gross Unrealized Losses and Fair Value (Details) Sheet http://www.eyegatepharma.com/role/FairValueAvailableforSaleInvestmentsGrossUnrealizedLossesandFairValueDetails Fair Value - Available-for-Sale Investments Gross Unrealized Losses and Fair Value (Details) Details 50 false false R51.htm 9955533 - Disclosure - Fair Value - Schedule of Obligations for Each Relevant Transaction (Details) Sheet http://www.eyegatepharma.com/role/FairValueScheduleofObligationsforEachRelevantTransactionDetails Fair Value - Schedule of Obligations for Each Relevant Transaction (Details) Details 51 false false R52.htm 9955534 - Disclosure - Fair Value - Narrative (Details) Sheet http://www.eyegatepharma.com/role/FairValueNarrativeDetails Fair Value - Narrative (Details) Details 52 false false R53.htm 9955535 - Disclosure - Fair Value - Unobservable Level 3 Inputs (Details) Sheet http://www.eyegatepharma.com/role/FairValueUnobservableLevel3InputsDetails Fair Value - Unobservable Level 3 Inputs (Details) Details 53 false false R54.htm 9955536 - Disclosure - Fair Value - Estimate to Measure Contingent Consideration Unobservable Level 3 In-process R&D (Details) Sheet http://www.eyegatepharma.com/role/FairValueEstimatetoMeasureContingentConsiderationUnobservableLevel3InprocessRDDetails Fair Value - Estimate to Measure Contingent Consideration Unobservable Level 3 In-process R&D (Details) Details 54 false false R55.htm 9955537 - Disclosure - Prepaid Expenses and Other Current Assets (Details) Sheet http://www.eyegatepharma.com/role/PrepaidExpensesandOtherCurrentAssetsDetails Prepaid Expenses and Other Current Assets (Details) Details http://www.eyegatepharma.com/role/PrepaidExpensesandOtherCurrentAssetsTables 55 false false R56.htm 9955538 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details) Sheet http://www.eyegatepharma.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails Property and Equipment - Schedule of Property and Equipment (Details) Details 56 false false R57.htm 9955539 - Disclosure - Property and Equipment - Narrative (Details) Sheet http://www.eyegatepharma.com/role/PropertyandEquipmentNarrativeDetails Property and Equipment - Narrative (Details) Details 57 false false R58.htm 9955540 - Disclosure - Accrued Expenses (Details) Sheet http://www.eyegatepharma.com/role/AccruedExpensesDetails Accrued Expenses (Details) Details http://www.eyegatepharma.com/role/AccruedExpensesTables 58 false false R59.htm 9955541 - Disclosure - Intangible Assets and In-Process R&D - Narrative (Details) Sheet http://www.eyegatepharma.com/role/IntangibleAssetsandInProcessRDNarrativeDetails Intangible Assets and In-Process R&D - Narrative (Details) Details 59 false false R60.htm 9955542 - Disclosure - Intangible Assets and In-Process R&D - Schedule of Intangible Assets and In-process R&D (Details) Sheet http://www.eyegatepharma.com/role/IntangibleAssetsandInProcessRDScheduleofIntangibleAssetsandInprocessRDDetails Intangible Assets and In-Process R&D - Schedule of Intangible Assets and In-process R&D (Details) Details 60 false false R61.htm 9955543 - Disclosure - Capital Stock (Details) Sheet http://www.eyegatepharma.com/role/CapitalStockDetails Capital Stock (Details) Details http://www.eyegatepharma.com/role/CapitalStock 61 false false R62.htm 9955544 - Disclosure - Warrants (Details) Sheet http://www.eyegatepharma.com/role/WarrantsDetails Warrants (Details) Details http://www.eyegatepharma.com/role/WarrantsTables 62 false false R63.htm 9955545 - Disclosure - Equity Incentive Plan - Narrative (Details) Sheet http://www.eyegatepharma.com/role/EquityIncentivePlanNarrativeDetails Equity Incentive Plan - Narrative (Details) Details 63 false false R64.htm 9955546 - Disclosure - Equity Incentive Plan - Schedule of stock option activity (Details) Sheet http://www.eyegatepharma.com/role/EquityIncentivePlanScheduleofstockoptionactivityDetails Equity Incentive Plan - Schedule of stock option activity (Details) Details 64 false false R65.htm 9955547 - Disclosure - Equity Incentive Plan - Weighted-Average Assumptions (Details) Sheet http://www.eyegatepharma.com/role/EquityIncentivePlanWeightedAverageAssumptionsDetails Equity Incentive Plan - Weighted-Average Assumptions (Details) Details 65 false false R66.htm 9955548 - Disclosure - Equity Incentive Plan - Restricted Stock Activity (Details) Sheet http://www.eyegatepharma.com/role/EquityIncentivePlanRestrictedStockActivityDetails Equity Incentive Plan - Restricted Stock Activity (Details) Details 66 false false R67.htm 9955549 - Disclosure - Equity Incentive Plan - Stock-based Compensation (Details) Sheet http://www.eyegatepharma.com/role/EquityIncentivePlanStockbasedCompensationDetails Equity Incentive Plan - Stock-based Compensation (Details) Details 67 false false R68.htm 9955550 - Disclosure - Income Taxes - Schedule of Components of Loss Before Income Taxes (Details) Sheet http://www.eyegatepharma.com/role/IncomeTaxesScheduleofComponentsofLossBeforeIncomeTaxesDetails Income Taxes - Schedule of Components of Loss Before Income Taxes (Details) Details 68 false false R69.htm 9955551 - Disclosure - Income Taxes - Schedule of Components of Income Tax Expense (Details) Sheet http://www.eyegatepharma.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseDetails Income Taxes - Schedule of Components of Income Tax Expense (Details) Details 69 false false R70.htm 9955552 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation - 2025 (Details) Sheet http://www.eyegatepharma.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliation2025Details Income Taxes - Schedule of Effective Income Tax Rate Reconciliation - 2025 (Details) Details 70 false false R71.htm 9955553 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation - 2024 (Details) Sheet http://www.eyegatepharma.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliation2024Details Income Taxes - Schedule of Effective Income Tax Rate Reconciliation - 2024 (Details) Details 71 false false R72.htm 9955554 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) Sheet http://www.eyegatepharma.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) Details 72 false false R73.htm 9955555 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.eyegatepharma.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 73 false false R74.htm 9955556 - Disclosure - Income Taxes - Schedule of Income Taxes Paid, Net (Details) Sheet http://www.eyegatepharma.com/role/IncomeTaxesScheduleofIncomeTaxesPaidNetDetails Income Taxes - Schedule of Income Taxes Paid, Net (Details) Details 74 false false R75.htm 9955557 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.eyegatepharma.com/role/CommitmentsandContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 75 false false R76.htm 9955558 - Disclosure - Commitments and Contingencies - Schedule of Future Annual Minimum Lease Payments (Details) Sheet http://www.eyegatepharma.com/role/CommitmentsandContingenciesScheduleofFutureAnnualMinimumLeasePaymentsDetails Commitments and Contingencies - Schedule of Future Annual Minimum Lease Payments (Details) Details 76 false false R77.htm 9955559 - Disclosure - Employee Benefit Plans (Details) Sheet http://www.eyegatepharma.com/role/EmployeeBenefitPlansDetails Employee Benefit Plans (Details) Details http://www.eyegatepharma.com/role/EmployeeBenefitPlans 77 false false R78.htm 9955560 - Disclosure - Segment Information - Narrative (Details) Sheet http://www.eyegatepharma.com/role/SegmentInformationNarrativeDetails Segment Information - Narrative (Details) Details 78 false false R79.htm 9955561 - Disclosure - Segment Information - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details) Sheet http://www.eyegatepharma.com/role/SegmentInformationReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails Segment Information - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details) Details 79 false false R80.htm 9955562 - Disclosure - Roll-forward of TOI Activity (Details) Sheet http://www.eyegatepharma.com/role/RollforwardofTOIActivityDetails Roll-forward of TOI Activity (Details) Details http://www.eyegatepharma.com/role/RollforwardofTOIActivityTables 80 false false R81.htm 9955563 - Disclosure - Prepaid Collaboration Expenses and Accrued Collaboration Credit (Details) Sheet http://www.eyegatepharma.com/role/PrepaidCollaborationExpensesandAccruedCollaborationCreditDetails Prepaid Collaboration Expenses and Accrued Collaboration Credit (Details) Details http://www.eyegatepharma.com/role/PrepaidCollaborationExpensesandAccruedCollaborationCreditTables 81 false false R82.htm 9955564 - Disclosure - Subsequent Events (Details) Sheet http://www.eyegatepharma.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.eyegatepharma.com/role/SubsequentEvents 82 false false All Reports Book All Reports kprx-20251231.htm kprx-20251231.xsd kprx-20251231_cal.xml kprx-20251231_def.xml kprx-20251231_lab.xml kprx-20251231_pre.xml kprx-20251231_g1.jpg kprx-20251231_g2.jpg http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/cyd/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 true true